Implementation of the SoHO Regulation and the Management of the Plasma Collection System in the Czech Republic –⁠ discussion and position of an interdisciplinary panel

Czech version

Authors: V. Černý ^1-5; J. Blatný ⁶; M. Bohoněk ^7,8; H. Lejdarová ^9-11; A. Šedivá ¹²; P. Turek ¹³
Authors‘ workplace: Klinika anesteziologie, perioperační a intenzivní medicíny, Masarykova nemocnice v Ústí nad Labem, Univerzita J. E. Purkyně v Ústí nad Labem ¹; Národní institut kvality a excelence zdravotnictví, Praha ²; Klinika anesteziologie, resuscitace a intenzivní medicíny LF UK, Hradec Králové ³; Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Canada ⁴; Ústav klinických oborů a biomedicíny, Technická univerzita Liberec ⁵; Oddělení dětské hematologie a biochemie, MU a FN Brno ⁶; Ústav laboratorní medicíny, hematologie a transfuziologie FBMI ČVUT a ÚVN – VFN, Praha ⁷; Fakulta biomedicínského inženýrství, ČVUT Praha ⁸; Transfuzní a tkáňové oddělení, FN Brno ⁹; Katedra laboratorních metod LF MU, Brno ¹⁰; Interní hematologická a onkologická klinika LF MU Brno ¹¹; Ústav imunologie 2. LF UK a FNMH, Praha 13 Transfuzní oddělení, Fakultní Thomayerova nemocnice, Praha ¹²
Published in: Transfuze Hematol. dnes,32, 2026, No. Ahead of Print, p. 1-5.
Category: Best Practices
doi: https://doi.org/10.48095/cctahd202611

Overview

We present the conclusions and recommendations of an interdisciplinary expert panel regarding the long-term sustainability of the Czech Republic’s self-sufficiency in plasma collection in connection with the adoption of the new Regulation of the European Parliament and of the Council on substances of human origin (SoHO).

Keywords:

plasma – plasma donors – plasma collection – SoHO

Labels

Haematology Internal medicine Clinical oncology

Concurrent occurrence of BCR::ABL1-positive chronic myeloid leukaemia and Philadelphia-negative myeloproliferative neoplasm

Recommendation of the Society for Transfusion Medicine No. 20 Cold red blood cell antibodies testing before cardiothoracic surgery on cardiopulmonary bypass

Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients

Acute myeloid leukemia – how the approach to diagnosis, risk stratification, and treatment options has changed

Antifungal prophylaxis in patients with acute myeloid leukaemia treated with venetoclax and azacitidine

Thrombotic microangiopathy in the maternity ward from the anaesthesiologist‘s perspective – a case study

Article was published in

Transfusion and Haematology Today

2026 Issue Ahead of Print